NCT03554109 2025-02-21
TNBC
ImmunityBio, Inc.
Phase 2 Withdrawn
Clinical Trials
6 trialsNCT01658033 2015-09-09
Bevacizumab Plus Modified FOLFOX6 Regimen as the Salvage Treatment in Metastatic Breast Cancer (MBC) Patients
Fudan University
Phase 2 Completed
NCT01231802 2012-07-17
Study of Eniluracil + 5-Fluorouracil (5-FU) + Leucovorin Versus Capecitabine in Metastatic Breast Cancer
Adherex Technologies, Inc.
Phase 2 Unknown
NCT00005608 2012-06-06
Fluorouracil-Uracil and Leucovorin in Treating Women With Metastatic Breast Cancer
Northwestern University
Phase 2 Terminated
NCT00010075 2008-07-24
Combination Chemotherapy in Treating Older Women With Metastatic Breast Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00001498 2008-03-04
A Pilot Trial of Sequential Chemotherapy With Antimetabolite Induction, High-Dose Alkylating Agent Consolidation With Peripheral Blood Progenitor Cell Support, and Intensification With Paclitaxel and Doxorubicin for Patients With High-Risk Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed